SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,944.28 -12.99
( -0.02%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,824.26 31.76
(0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Alembic Pharmaceuticals consolidated net profit rises 12.11% in the June 2026 quarter

Aug 04,2026

Net profit of Alembic Pharmaceuticals rose 12.11% to Rs 173.07 crore in the quarter ended June 2026 as against Rs 154.38 crore during the previous quarter ended June 2025. Sales rose 25.66% to Rs 2149.77 crore in the quarter ended June 2026 as against Rs 1710.72 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2149.77	1710.72	26
OPM %	15.44	16.42	-
PBDT	319.57	263.88	21
PBT	221.86	190.11	17
NP	173.07	154.38	12

76,944.28 -12.99 ( -0.02%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,431.13 119.20 (0.18%)

10,824.26 31.76 (0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)